Login to Your Account



Neurotech Refocuses On Eye Diseases, Ends French Activities

By James Etheridge


Wednesday, August 28, 2002
PARIS - Neurotech SA, a French biotechnology company set up in 1995 to develop cell-based therapies for diseases of the eye and the central nervous system, will focus solely on ophthalmology from now on and has halted its other research and development programs. (Bioworld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription